SIGNALLING PATHWAYS AND MOLECULAR TARGETS FOR SKIN CANCER: INVOLVEMENT OF CDK2 INHIBITION. (2018). Nirma University Journal of Pharmaceutical Sciences, 5(1), 41-58. https://doi.org/10.5281/